SCHEMBL3174890

SCHEMBL3174890

[NH]c1c(C(F)(F)F)cc(C(F)(F)F)cc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.40
CACNA1H O95180 7/20 0.35
CACNA1C Q13936 3/20 0.35
CACNA1B Q00975 2/20 0.35
TSHR P16473 4/20 0.33
IDO1 P14902 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CACNA1G O43497 2/20 0.32
AR P10275 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
HIF1A Q16665 1/20 0.31
TXNRD1 Q16881 1/20 0.31
TXNRD3 Q86VQ6 1/20 0.31
TXNRD2 Q9NNW7 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
GLA P06280 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11603910 0.77 CES2 (0.43) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL6756054 0.74 CES2 (0.41) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL15933661 0.74 CES2 (0.41) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL6061078 0.72 CES2 (0.56) CES2TSHRALDH1A1ARMAPK1
SCHEMBL3194447 0.72 CES2 (0.45) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL23174658 0.72 CES2 (0.40) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL16554203 0.72 CES2 (0.40) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL3190814 0.72 CES2 (0.40) CES2CACNA1HCACNA1CCACNA1BIDO1
SCHEMBL1042998 0.72 CES2 (0.40) CES2CACNA1HCACNA1CCACNA1BTSHR
SCHEMBL23174646 0.72 CES2 (0.40) CES2CACNA1HCACNA1CCACNA1BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659416-B2 Monomolecular conductive complex, conductive self-assembled film and assembly of electrode composed of metal and semiconductor making use of the same TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-09 US disclosed
US-20090036698-A1 Monomolecular Conductive Complex, Conductive Self-Assembled Film and Assembly of Electrode Composed of Metal and Semiconductor Making Use of the Same TOKYO INSTITUTE OF TECHNOLOGY 2009-02-05 US disclosed
EP-1862453-A1 MONOMOLECULAR CONDUCTIVE COMPLEX, CONDUCTIVE SELF-ASSEMBLED FILM AND ASSEMBLY OF ELECTRODE COMPOSED OF METAL AND SEMICONDUCTOR MAKING USE OF THE SAME Tokyo Institute of Technology (JP) 2007-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036698-A1 Monomolecular Conductive Complex, Conductive Self-Assembled Film and Assembly of Electrode Composed of Metal and Semiconductor Making Use of the Same CNTN1, GAP43, AP3M1 CES2 3287/4885CACNA1H 627/4885CACNA1C 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.